Effective January 1, 2021, the Kentucky Cabinet for Health and Family Services (CHFS) will utilize Version 4.2B of the American Society for Automation in Pharmacy (ASAP) Prescription Drug Monitoring Program Standard for reporting controlled substance data to KASPER. Members may want to take the following actions to prepare:
- Review the implementation guide for Version 4, Release 2B of the ASAP Prescription Drug Monitoring Program Standard
- Review the KASPER Controlled Substance Reporting Guide:
- By Jan. 1, 2021, ensure your pharmacy systems are reporting two newly required fields:
1. DSP12 Transmission Form of Rx Origin Code.
2. DSP13 Partial Fill Indicator. CHFS will require this field for all prescription records reported to KASPER.
Additionally, effective January 1, 2021, when the PAT02 value is 07 for Social Security Number, the vast majority of records, the PAT03 value must be nine numeric digits or the record will be rejected with a fatal error and will need to be corrected.
Lastly, to support EPCS, KASPER will track the DSP20 – Electronic Prescription Reference Number, and DSP21 – Electronic Prescription Order Number fields. Reporting these fields is optional, but KASPER is requesting that pharmacies report this if capable. For further detail, please contact KASPER administration at (502) 564-2815 or eKASPER.admin@ky.gov.
Also in KY. NACDS reminds members that Kentucky Revised Statute 218A.182 mandates the electronic prescribing of controlled substances (EPCS) effective January 1, 2021. The Kentucky mandate is similar to the federal Medicare Part D EPCS mandate effective January 1, 2021, but applies to all controlled substances prescribed in Kentucky. Click here for more information, including criteria and process for an exemption.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.